Security key
766559603
- Security type / class
- Equity / Stock
- Total 13F shares
- 106,260,617
- Total 13F value
- $114,759,921
- Share change
- -4,503,681
- Put/Call ratio
- 11%
- SEC-reported price per share
- $1.08
- Number of holders
- 103
- Value change
- -$5,306,571
- Number of buys
- 39
- Number of sells
- 50
Open additional details 1 more signal available
Report period
Q3 2023
Institutions
103
Top holders
10
RIGL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
RIGEL PHARMACEUTICALS INC SEC filings
RIGEL PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 766559603
Recent filing periods:
Ownership snapshot
Top reported holders of RIGL - RIGEL PHARMACEUTICALS INC COM - Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F
Highest disclosed value: $22,059,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $22.06M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$22.06M
BlackRock Finance, Inc.
$18.86M
Soleus Capital Management, L.P.
$18.29M
VANGUARD GROUP INC
$14.11M
ACADIAN ASSET MANAGEMENT LLC
$5.91M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$22,059,000
17,100,000 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$18,856,694
14,617,592 shares
|
— | 30 Jun 2023 |
| Soleus Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$18,289,639
14,178,015 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$14,108,509
10,936,829 shares
|
— | 30 Jun 2023 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$5,908,000
4,581,512 shares
|
— | 30 Jun 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$5,799,527
4,495,757 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
103
Shares
106,260,617
Rows available
103
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q1 2026 Across Filers
Q1 2026 holders
8
Q3 2023 holders
103
Holder diff
95
| Investor | Q1 2026 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend